Related Experiment Video

Updated: Aug 26, 2025

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
05:10

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

12.3K

Cellular immunotherapy for medulloblastoma

Michael Y Schakelaar1, Matthijs Monnikhof1, Sandra Crnko1,2

  • 1Department of Pathology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.

Neuro-Oncology
|October 11, 2022
PubMed

Insights

Cellular immunotherapy offers a promising avenue for treating pediatric medulloblastoma (MB), a challenging childhood brain cancer. This review explores current research and future directions for enhancing MB treatment efficacy and safety.

Area of Science:

  • Pediatric neuro-oncology
  • Immunology
  • Cancer therapy

Background:

  • Medulloblastoma (MB) is the most common malignant pediatric brain tumor, with current treatments yielding suboptimal outcomes and significant long-term side effects.
  • A substantial portion of treated patients do not achieve a cure, highlighting the urgent need for novel therapeutic strategies.
  • Cellular immunotherapy, successful in other cancers, remains underexplored for MB.

Approach:

  • This review provides a comprehensive overview of cellular immunotherapy for medulloblastoma.
  • It covers fundamental in vitro research, in vivo models, and ongoing clinical trials.
  • Findings are compared with cellular immunotherapy approaches used for glioma, an analogous intracranial tumor.

Key Points:

  • Current medulloblastoma therapies (surgery, radiation, chemotherapy) have limitations in efficacy and tolerability.
  • Cellular immunotherapy leverages immune cells to target cancer, showing potential for improved outcomes.
  • Research is progressing from basic science to clinical applications for MB immunotherapy.

Conclusions:

  • Significant advancements are needed to optimize cellular immunotherapy for medulloblastoma.
  • Future research should focus on enhancing treatment efficacy and patient safety.
  • Comparative analysis with glioma immunotherapy provides valuable insights for MB treatment development.
Keywords:
cellular immunotherapycytotoxic lymphocytesmedulloblastoma

More Related Videos

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

8.0K
Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells06:32

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Published on: September 1, 2010

16.4K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
642
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
69.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
477
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.1K